20080327 FDA Early Communication about Ongoing Safety Review

FDA issues a Communication about an Ongoing Safety Review of Regranex (marketed as Becaplermin).
FDA issues an Early Communication about an Ongoing Safety Review of Ziagen (marketed as Abacavir) and Videx (marketed as Didanosine).
FDA issues an Early Communication about an Ongoing Safety Review of Montelukast (marketed as Singulair).